CareDX Stock News & Updates

[WKN: A118WG | Symbol: CDNA]

CareDx: 39% Revenue Growth and New Cancer Tests – The Next Phase of Growth Begins

The transplantation test volume is growing by 21%. Medicare ensures regular cost reimbursement. The...

CareDx: The Specialist for Life After Transplantation

CareDx is a US-based specialist in molecular diagnostic testing and digital software solutions that...

CareDx: Specialist in Transplant Diagnostics Grows by 52% - Expansion into Oncology!

CareDx focuses on testing services for patients after organ transplants. The acquisition of Naveris...

CareDX (CDNA) in Pivotal Point Check: New 52-Week High After Earnings Fireworks, Medicare Reimbursement Breakthrough, and Forecast Increase!

Strong Q2 Growth: Revenue increase of 52% to 132 million USD significantly exceeds analyst estimates....

Pivotal-Point Monitoring CareDX (CDNA): Transplant Diagnostics Specialist Sees High Demand for Molecular Monitoring Tests

CareDX is a precision medicine company that specializes in diagnostic solutions for organ transplantation....

CareDX: Stock Rally After Medicare Clarity! CareDX Revolutionizes Organ Monitoring with AI Diagnostics!

Investors in the "Healthcare" sector can breathe a sigh of relief. The sector is currently performing...

CareDx: AI-supported Transplant Medicine Accelerates Revenue Growth to 39%!

CareDx (CDNA) has specialized as a precision medicine company in the discovery, development, and marketing...

  • ‹
  • 1
  • ›